Home Crystal structure of 2-(4-chlorophenyl)-3-phenyl-1,8-naphthyridine, C20H13N2Cl
Article Open Access

Crystal structure of 2-(4-chlorophenyl)-3-phenyl-1,8-naphthyridine, C20H13N2Cl

  • Yi-Biao Li , Lu Chen , Zhong-Zhi Zhu , Yu-Bing Huang and Xiu-Wen Chen EMAIL logo
Published/Copyright: October 15, 2018

Abstract

C20H13N2Cl, monoclinic, P21/n (no. 14), a = 6.179(4) Å, b = 11.666(8) Å, c = 22.460(15) Å, β = 95.837°, V = 1610.6(19) Å3, Z = 4, Rgt(F) = 0.0507, wRref(F2) = 0.1599, T = 296(2) K.

CCDC no.: 1843849

The crystal structure is shown in the figure. Tables 1 and 2 contain details on crystal structure and measurement conditions and a list of the atoms including atomic coordinates and displacement parameters.

Table 1:

Data collection and handling.

Crystal:Colorless block
Size:0.32 × 0.27 × 0.24 mm
Wavelength:Mo Kα radiation (0.71073 Å)
μ:0.24 mm−1
Diffractometer, scan mode:Bruker APEX-II, φ and ω-scans
θmax, completeness:25.5°, >99%
N(hkl)measured, N(hkl)unique, Rint:12531, 3334, 0.033
Criterion for Iobs, N(hkl)gt:Iobs > 2 σ(Iobs), 2062
N(param)refined:208
Programs:Bruker programs [1], SHELX [2], OLEX2 [3]
Table 2:

Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2).

AtomxyzUiso*/Ueq
Cl1−0.11456(12)0.32015(7)0.44569(3)0.1187(4)
N10.7453(3)0.51981(14)0.17572(8)0.0758(5)
N20.5456(3)0.52907(13)0.25657(7)0.0610(4)
C10.9010(5)0.5622(2)0.14642(10)0.0852(7)
H10.9369220.5219210.1130510.102*
C21.0160(4)0.6620(2)0.16131(10)0.0829(7)
H21.1247820.6868910.1386600.099*
C30.9663(4)0.72223(19)0.20942(9)0.0719(6)
H31.0388560.7902010.2200390.086*
C40.8038(3)0.68094(15)0.24322(8)0.0584(5)
C50.6985(3)0.57806(16)0.22508(8)0.0604(5)
C60.4945(3)0.58075(16)0.30515(8)0.0567(5)
C70.5828(3)0.68933(15)0.32489(8)0.0562(5)
C80.7369(3)0.73620(16)0.29356(8)0.0592(5)
H80.7991350.8060630.3056760.071*
C90.5032(3)0.75243(16)0.37566(8)0.0602(5)
C100.6345(4)0.76961(19)0.42816(9)0.0750(6)
H100.7757860.7410380.4322990.090*
C110.5567(6)0.8294(2)0.47487(11)0.0950(8)
H110.6449850.8390690.5105780.114*
C120.3521(6)0.8742(2)0.46896(14)0.1008(9)
H120.3018370.9145670.5004870.121*
C130.2216(4)0.8599(2)0.41720(15)0.1007(9)
H130.0824870.8912010.4129510.121*
C140.2960(4)0.7990(2)0.37112(11)0.0830(7)
H140.2049100.7887980.3359380.100*
C150.3398(3)0.51849(15)0.34029(8)0.0578(5)
C160.3816(4)0.5040(2)0.40085(10)0.0827(7)
H160.5067590.5360650.4205880.099*
C170.2435(4)0.4433(2)0.43311(10)0.0896(8)
H170.2753080.4341770.4741990.108*
C180.0596(4)0.39664(19)0.40461(11)0.0751(6)
C190.0141(3)0.40930(19)0.34424(11)0.0766(6)
H19−0.1124170.3777640.3249510.092*
C200.1545(3)0.46851(17)0.31188(9)0.0650(5)
H200.1247430.4749920.2705920.078*

Source of material

Under N2 atmosphere, tert.-BuOK (50 mol%), Xantphos (3 mol%), Ru3(CO)12 (1 mol%), (2-aminopyridin-3-yl)methanol (0.5 mmol), 1-(4-chlorophenyl)-2-phenylethan-1-ol (0.5 mmol) and tert.-amyl alcohol (1.0 mL) were introduced in a Schlenk tube (25 mL), successively. Then, the Schlenk tube was closed and the resulting mixture was stirred at 403 K for 5 h. After cooling to room temperature, the reaction mixture was concentrated by removing the solvent under vacuum, and the residue was purified by preparative TLC on silica, eluting with petroleum ether (333–363 K): ethyl acetate (6:1, v/v) to give 2-(4-chlorophenyl)-3-phenyl-1,8-naphthyridine as a colourless blocks.

Experimental details

Hydrogen atoms were placed in their geometrically idealized positions and constrained to ride on their parent atoms.

Discussion

1,8-Naphthyridine ring systems are attractive structural motifs because of their wide distribution in bioactive molecules and pharmaceuticals [4], [5]. Hence, there is considerable interest in the development of effective methods for the synthesis of 1,8-naphthyridine and its analogues [6], [7]. However, the crystal structure of 2-(4-chlorophenyl)-3-phenyl-1,8-naphthyridine has not been reported before. Herein the crystal structure of the title compound is described to enrich the related crystal structures of 2-(4-chlorophenyl)-3-phenyl-1,8-naphthyridine.

As in our previous study [8], the title compound, built up by the C20H13N2Cl molecules, has been synthesized. The single crystal structure verifies that all bond lengths are in normal ranges [8], [9].

Acknowledgements

The work was supported by the Foundation of the Department of Education of Guangdong Province (2016KTSCX144, 2017KZDXM085) and the High-level Scientific Research Foundation for the introduction of talent (AL2018008).

References

1. Bruker: APEX2, SAINT and SADABS. Brucker AXS Inc., Madison, WI, USA (2009).Search in Google Scholar

2. Sheldrick, G. M.: SHELXT-Integrated space-group and crystal-structure determination. Acta Crystallogr. C71 (2015) 3–8.10.1107/S2053273314026370Search in Google Scholar PubMed PubMed Central

3. Dolomanov, O. V.; Bourhis, L. J.; Gildea, R. J.; Howard, J. A. K.; Puschmann, H.: OLEX2: a complete structure solution, refinement and analysis program. J. Appl. Cryst. 42 (2009) 339–341.10.1107/S0021889808042726Search in Google Scholar

4. Hartner, F. W.; Hsiao, Y.; Eng, K. K.; Rivera, N. R.; Palucki, M.; Tan, L.; Yasuda, N.; Hughes, D. L.; Weissman, S.; Zewge, D.; King, T.; Tschaen, D.; Volante, R. P.: Methods for the synthesis of 5,6,7,8-tetrahydro-1,8-naphthyridine fragments for αVβ3 integrin antagonists. J. Org. Chem. 69 (2004) 8723–8730.10.1021/jo0486950Search in Google Scholar PubMed

5. Ferrarini, P. L.; Mori, C.; Manera, C.; Martinelli, A.; Mori, F.; Saccomanni, G.; Barili, P. L.; Betti, L.; Giannaccini, G.; Trincavelli, L.; Lucacchini, A.: A novel class of highly potent and selective A 1 adenosine antagonists: structure-affinity profile of a series of 1,8-naphthyridine derivatives. J. Med. Chem. 43 (2000) 2814–2823.10.1021/jm990321pSearch in Google Scholar PubMed

6. Zhang, S. L.; Deng, Z. Q.: Synthesis of quinolines and naphthyridines via catalytic retro-aldol reaction of β–hydroxyketones with ortho-aminobenzaldehydes or nicotinaldehydes. Org. Biomol. Chem. 14 (2016) 8966–8970.10.1039/C6OB01452FSearch in Google Scholar PubMed

7. Ma, W.; Chen, F.; Liu, Y.; He, Y. M.; Fan, Q. H.: Ruthenium-catalyzed enantioselective hydrogenation of 1,8-naphthyridine derivatives. Org. Lett. 18 (2016) 2730–2733.10.1021/acs.orglett.6b01186Search in Google Scholar PubMed

8. Jia, G.-K.; Chen, X.-M.; He, F.-L.; Chen, X.-W.; Wang, Z.-C.: Crystal structure of 2-(3,4-dimethylphenyl)-1,8-naphthyridine, C16H14N2. Z. Kristallogr. NCS 233 (2018) 819–820.10.1515/ncrs-2018-0031Search in Google Scholar

9. Rosin, R.; Seichter, W.; Mazik, M.: Crystal structures of the dioxane hemisolvates of N-(7-bromomethyl-1,8-naphthyridin-2-yl)acetamide and bis[N-(7-dibromomethyl-1,8-naphthyridin-2-yl)acetamide]. Acta Crystallogr. E73 (2017) 1409–1413.10.1107/S2056989017012208Search in Google Scholar PubMed PubMed Central

Received: 2018-07-30
Accepted: 2018-10-07
Published Online: 2018-10-15
Published in Print: 2018-12-19

©2018 Yi-Biao Li et al., published by De Gruyter, Berlin/Boston

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Articles in the same Issue

  1. Cover and Frontmatter
  2. Crystal structure of bis(6,6′-((ethane-1,2-diylbis(azanylylidene))bis(methanylylidene))bis(2,4-diiodophenolato)-κ4N,N′,O,O′)cer(IV), C32H20CeI8N4O4
  3. Crystal structure of (6,6′-((ethane-1,2-diylbis(azanylylidene))bis(methanylylidene))bis(2-chlorophenolato-κ2N,O))copper(II), C16H12Cl2CuN2O2
  4. Crystal structure of poly[aqua-(μ3-4-(pyridin-4-yl)isophthalato-κ4O,O′:O′′:O′′′)-(μ2-5-carboxy-2-(pyridin-4-yl)benzoato-κ2O:O′)samarium(III)], C26H18N2O9Sm
  5. Crystal structure of 1-{4-[(2-hydroxy-5-nitrobenzylidene)amino]phenyl}ethanone O-methyl oxime, C16H15N3O4
  6. Synthesis and crystal structure of bis(μ2-acetato-κ2O:O′)-bis(μ2-1-(8-(2-oxidophenyl)-3,6-dioxa-2,7-diazaocta-1,7-dien-1-yl)naphthalen-2-olato-κ6O:O,N,N′,O′:O′)trizinc(II), C44H38Zn3N4O12
  7. Synthesis and crystal structure of bis(μ2-acetato-κ2O:O′)–bis(μ2–(8-(2-oxidophenyl)-3,6-dioxa-2,7-diazaocta-1,7-dien-1-yl)naphthalen-2-olato-κ6O:O,N,N′,O′:O′)tricobalt(II), C44H38Co3N4O12
  8. Crystal structure of poly[aqua(μ4-2,2′,2′′-nitrilotriacetato-κ6O1,O3,O5:O2:O4:O6)-yttrium(III)], C6H8NO7Y
  9. Crystal structure of catena-poly[bromido-(μ2-pyrazine-2-carboxylato-κ3N:N′,O)copper(II)], C10H6N4Cu2O4Br
  10. Crystal structure of poly[dodekais(μ2-2,6-difluorobenzoato-κ2O:O′)-bis((μ3-hexamethylenetetramine-κ3N:N′:N′′)hexacopper(II)], C48H30N4O12F12Cu3
  11. Crystal structure of methyl 4-(4-hydroxy-3-nitrophenyl)-2-methyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline-3-carboxylate, C18H18N2O6
  12. Crystal structure of N-phenyl-2-(propan-2-ylidene)hydrazine-1-carbothioamide, C10H13N3S
  13. Crystal structure of sodium caesium zinc phosphate, NaCsZnP2O7
  14. Crystal structure of methyl 4-(4-isopropylphenyl)-2,7,7-trimethyl-5-oxo-1,4,5,6,7,8-hexahydro-quinoline-3-carboxylate, C23H29NO3
  15. Crystal structure of catena-poly[bis(μ2-1,3-di(4H-1,2,4-triazol-4-yl)benzene-κ2N:N′)-bis(thiocyanato-κ1N)cobalt(II), C22H16CoN14S2
  16. Crystal structure of catena-poly[(μ2-2,5-di(pyridin-3-yl)-1,3,4-thiadiazole-κ2N:N′)-bis(2,5-di(pyridin-3-yl)-1,3,4-thiadiazole-κ1N)-bis(thiocyanato-κ1N)cobalt(II)], C38H24CoN14S5
  17. Crystal structure of bis(2,5-di(pyridin-2-yl)-1,3,4-thiadiazole-κ2N,N′)-bis(thiocyanato-κ1N)cobalt(II), C26H16CoN10S4
  18. Crystal structure of (bis((1H-benzo[d]imidazol2-yl)methyl)amine-κ3N,N′,N′′)-(pyridine-2,6-dicarboxylato-κ3N,O,O′)zinc(II) — methanol — water (1/2/1), C25H28N6O7Zn
  19. Crystal structure of catena-poly[triaqua-(μ2-5-methoxy-isophthalato-κ2O:O′)copper(II)], C9H12CuO8
  20. Structure and photochromism of 1-[2-methyl-5-phenyl-3-thienyl]-2-[2-methyl-5-(4-chlorophenyl)-3-thienyl]3,3,4,4,5,5-hexafluorocyclopent-1-ene, C27H16ClF6S2
  21. Crystal structure of methyl 4-(3-phenoxyphenyl)-2,7,7-trimethyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline-3-carboxylate, C26H27NO4
  22. Crystal structure of poly[diaqua-di-μ2-hydroxido-(μ4-3,4,5,6-tetrafluoro-1,2-phthalato-κ4O:O′:O′′:O′′′)-(μ4-3,4,5,6-tetrafluoro-1,2-phthalato-κ5O,O:O′:O′′:O′′′)disamarium(III)] – bipyridine (2/1), C21H11NF16O12Sm2
  23. Crystal structural of diethyl 4-(3,5-dibromo-4-hydroxyphenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate, C19H21Br2NO5
  24. Crystal structure of catena-poly[tetraaqua(μ2-4-(1H-imidazol-1-yl)pyridine-κ2N:N′))zinc(II)] thiophene-2,5-dicarboxylate, C14H17N3O8ZnS
  25. Crystal structure of (20S)-20-(dimethylamino)-3-(tigloylamino)-5α-pregn-2,16-dien-4-one, C28H42N2O2
  26. Crystal structure of rac-trans-N,N′-bis(3,5-diiodosalicylidene)-1,2-cyclohexanediamine, C20H18I4N2O2
  27. Crystal structure of 2-bromo-7-(4-(dimethylamino)phenyl)-10-methylacridin-9 (10H)-one, C22H19BrN2O
  28. Crystal structure of catena-poly[(μ2-pentane-1,5-dicarboxylato-κ2O:O′)-(μ2-2-[(1H-imidazol-1-yl)methyl]-6-methyl-1H-benzimidazole-κ2N:N′)zinc(II)] sesquihydrate, C17H21N4O5.5Zn
  29. Crystal structure of ethyl 2-amino-4-(3,4-difluorophenyl)-5-oxo-4H,5H-pyrano[3,2-c] chromene-3-carboxylate, C21H15F2NO5
  30. Crystal structure of 9-(5-methylthiophen-2-yl)-3,4,5,6,7,9-hexahydro-1H-xanthene-1,8(2H)-dione, C18H18O3S
  31. Crystal structure of [5,5′-((propane-1,3-diylbis(azanylylidene))bis(ethan-1-yl-2-ylidene))bis(3-(ethoxycarbonyl)-2,4-dimethylpyrrol-1-ido)-κ4N,N′,N′′,N′′′]nickel(II), C23H30N4O4Ni
  32. Crystal structure of (Z)-2-(2-(1,3-dioxo-1-(phenylamino)butan-2-ylidene)hydrazineyl) terephthalic acid-dimethylsulfoxide (1/1), C18H15N3O6 ⋅ C2H6OS
  33. Crystal structure of (2E,4Z)-dimethyl 4-((phenylamino)methylene)pent-2-enedioate, C14H15N1O4
  34. Crystal structure of (2Z,2′Z)-1,1′-(pyridine-2,6-diyl) bis(3-hydroxy-3-phenylprop-2-en-1-one), C23H17NO4
  35. Crystal structure of ethyl 2-amino-4-(3-bromophenyl)-5-oxo-4H,5H-pyrano[3,2-c]chromene-3-carboxylate, C21H16BrNO5
  36. Crystal structure of bis(μ2-3,5-dichloro-2-oxidobenzoato-κ4O,O′:O′,O′′)-hexakis(μ2-pivalato-κ2O:O′)-bis(pivalato-κ2O,O′)-tetrakis(1,10-phenanthroline-κ2N,N′)tetragadolinium(III), C102H108Cl4Gd4N8O22
  37. Crystal structure of catena-poly[aqua-bis(formato-κ1O)-(μ2-1,1′-(oxybis(1,4-phenylene))-bis(1H-1,2,4-triazole)-κ2N:N′)copper(II)]hydrate, C18H16CuN6O6
  38. Crystal structure of 5-bromo-2-(naphthalen-6-yl)pyridine, C15H10BrN
  39. Crystal structure of N-(4-methoxybenzyl)pyridazin-3-amine- a rare Z′ = 4 structure, C12H13N3O
  40. Crystal structure of bis(perchlorato-κ1O)-bis(3,4,5-trimethoxy-N-(pyridin-2-yl)benzamide-κ2N,O)copper(II), C32H30Cl2CuN4O16
  41. Crystal structure of methyl 4-methyl-2,5-di(pyridin-4-yl)-1H-pyrrole-3-carboxylate monohydrate C17H15N3O2⋅H2O
  42. Crystal structure of dimethyl 5-(10-(methoxycarbonyl)anthracen-9-yl) isophthalate,C26H20O6
  43. Crystal structure of tert-butyl (R)-(1-(benzylamino)-3-methoxy-1-oxopropan-2-yl)carbamate, C16H24N2O4
  44. Crystal structure of aqua-bis(1,5-dimethyl-2-phenyl-4-(((E)-4-pyridylmethylene)amino)pyrazolidin-3-one-κN)-(nitrato-κO)-(nitrato-κ2O,O′)zinc(II), C34H34N10O9Zn
  45. Crystal structure of catena-poly[dichlorido-(μ2-1,5-dimethyl-2-phenyl-4-((pyridin-4-ylmethylene)amino)-1,2-dihydro-3H-pyrazol-3-one-κ2N:O)cobalt(II)] – methanol (1/1), C18H20Cl2CoN4O2
  46. Crystal structure of poly[diaqua-bis(μ2-1-(4-(1H-imidazol-1-yl)benzyl)-1H-1,2,4-triazole-κ2N:N′)manganese(II)]bis(2-carboxybenzoate) dihydrate, MnC40H40N10O12
  47. The crystal structure of 4-((3,4-dichlorobenzylidene)amino)-1,5-dimethyl-2-phenyl-1,2-dihydro-3H-pyrazol-3-one, C18H15Cl2N3O
  48. Crystal structure of bis(2-methoxy-6-((2-(pyrimidin-2-yl)hydrazono)methyl)phenolato-κ3N,N′,O)iron(III) perchlorate, C24H22N8O8ClFe
  49. The crystal structure of 2-[4-hydroxy-3-methoxyphenyl]-4,4,5,5-tetramethylimidazoline-3-oxide-1-oxyl, C14H19N2O4
  50. Crystal structure of diaqua-bis(3,3-dimethylacrylato-κ2O,O′)zinc(II), C10H18ZnO6
  51. Crystal structure of dichloro-tetrakis[(E)-1-(4-chlorophenyl)-4,4-dimethyl-2-(1H-1,2,4-triazol-1-yl)pent-1-en-3-ol-κN]cadmium (II), C60H74CdCl6N12O4
  52. Crystal structure of (20R)-20,25-epoxy-dammaran-3,12-dione, C30H48O3
  53. Crystal structure of (E)-3′,6′-bis(ethylamino)-2′,7′-dimethyl-2-((pyridin-2-ylmethylene)amino)spiro[isoindoline-1,9′-xanthen]-3-one, C32H31N5O2
  54. The crystal structure of 2-(4-fluorophenyl)-1,3,4-oxadiazole, C8H5FN2O
  55. Crystal structure of (2,2′-bipyridine-κ2N,N′)bis(tri(p-tolyl)phosphine-κP)copper(I) tetrafluoroborate – 4,4′-bipyridine (2/1), C57H54BCuF4N3P2
  56. The crystal structure of 2,6-dimethyl-3,5-dinitrocyclohexa-2,5-diene-1,4-dione, C8H6N2O6
  57. The crystal structure of 2,3-dimethyl-1,4-dinitrobenzene – a Z′ = 4 structure, C8H8N2O4
  58. Crystal structure of [(1,2-η)-1,2,3,4,5-pentamethyl-cyclopenta-2,4-dien-1-yl] (1,4,10,13-tetraoxa-7,16-diazacyclooctadecane-κ6N2,O4) rubidium (I), [Rb(diaza-18-crown-6)]Cp*, C22H41N2O4Rb
  59. Crystal structure of 2-(4-fluorophenyl)-N-phenyl-2-(phenylamino)ethanesulfonamide – toluene (1/0.5), C23.5H23FN2O2S
  60. Crystal structure of pyrene-4-aldehyde, C17H10O
  61. Crystal structure of 2-(furan-2-yl)-5-methyl-1,3-dioxane-5-carboxylic acid, C10H12O5
  62. Crystal structure of 2-(4-chlorophenyl)-3-phenyl-1,8-naphthyridine, C20H13N2Cl
  63. Crystal structure and photochromism of 1-(2-ethyl-5-formylthiophen-3yl)-2-(2-cyano-1,5-dimethyl-4-pyrrl)-3,3,4,4,5,5-hexafluorocyclopent-1-ene, C19H14F6N2OS
  64. Crystal structure of 2-(4-bromophenyl)-1,3-dimethyl-1H-perimidin-3-ium iodide, C19H16BrIN2
  65. Crystal structure of 2-(4-(dimethylamino)phenyl)-10-methylacridin-9(10H)-one, C22H20N2O
  66. Crystal structure of 4-(acetoxymethyl)-6-(3-acetyl-3-(4-fluorophenyl)thioureido)cyclohex-4-ene-1,2,3-triyl triacetate, C24H26FN2O9S
Downloaded on 21.11.2025 from https://www.degruyterbrill.com/document/doi/10.1515/ncrs-2018-0275/html
Scroll to top button